000			02090 a2200601 4500
005			20250517093153.0
264		0	_c20170726
008			201707s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2016.04.040 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Amin
245	0	0	_aMetabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation. _h[electronic resource]
260			_bCancer letters _c07 2016
300			_a149-57 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDeoxyglucose _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aG2 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aGenetic Predisposition to Disease
650	0	4	_aGlycolysis _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aMice
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aMutation
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenotype
650	0	4	_aPhenylurea Compounds _xpharmacology
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aPyruvates _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSorafenib
650	0	4	_aTandem Repeat Sequences
650	0	4	_aTime Factors
650	0	4	_afms-Like Tyrosine Kinase 3 _xantagonists & inhibitors
700	1		_aJu, Huai-Qiang
700	1		_aLiu, Kaiyan
700	1		_aZhan, Guilian
700	1		_aLiu, Daolu
700	1		_aWen, Shijun
700	1		_aGarcia-Manero, Guillermo
700	1		_aHuang, Peng
700	1		_aHu, Yumin
773	0		_tCancer letters _gvol. 377 _gno. 2 _gp. 149-57
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2016.04.040 _zAvailable from publisher's website
999			_c25976026 _d25976026